The simultaneous separation and quantification of the analytes within the minimum analysis time and the maximum resolution and efficiency are the main objectives in the development of a capillary electrophoretic method for the determination of solutes. In this paper we describe a specific, sensitive and robust method, using capillary zone electrophoresis with internal standard and UV detection, for the separation and quantification of the anti-arrhythmic drug mexiletine, its main phase I metabolites, and its main nitrogenous degradation product.
INTRODUCTION
Mexiletine, 1-(2,6-dimethylphenoxy)-2-propanamine (1), (Fig. 1) , is a class IB anti-arrhythmic drug [1] . Although it is primarily used in treating ventricular arrhythmias, its recent uses include chronic pain [2, 3] and myotonia [4] [5] [6] . It is extensively metabolized in humans by various pathways, such as carbon and nitrogen oxidation, reduction and conjugation reactions [7, 8] . Unchanged mexiletine in urine accounts for only 10% of the administered dose [9] . Determination of mexiletine and its metabolites in human plasma was reported by chromatographic methods, such as high-performance liquid chromatography [10, 11] , liquid chromatography with fluorescence detection [12] , electron capture gas-liquid chromatography [13] . Conceivably, new analytical methods capable of performing simultaneous determination of active compounds and their metabolites should be required. It is noteworthy that analytes with similar structural and physicochemical properties, as can be the parent compound and its metabolites, might suffer poor resolution, due to peak overlapping. Strong interaction with the stationary phases may cause peak asymmetry and low separation efficiency. As an alternative to chromatography, capillary electrophoresis (CE) may be employed in pharmaceutical analysis. The versatility of CE in the analysis allowed the separation of a wide array of pharmaceutically relevant analytes varying in polarity, size, and stereochemistry [14, 15] . The high efficiencies obtained in CE are well suited to complex mixtures in which the resolution of a large number of peaks in a short analysis time is desirable. Moreover, the United States Pharmacopoeia Convention in spring 1995 suggested reducing the number of reagents and *Address correspondence to these authors at the Dipartimento di FarmaciaScienze del Farmaco, Università degli Studi di Bari "Aldo Moro", via Orabona 4, 70126 Bari, Italy; Tel: +39 080 544 2745; Fax: +39 080 544 2724; E-mails: alessia.carocci@uniba.it; alessia.catalano@uniba.it materials used in pharmaceutical tests and assays that have the potential to cause harm to human health and the environment-a requisite which is wholly fulfilled by CE [16] . Chiral capillary electrophoresis using sulfatedcyclodextrin was successfully employed for the chiral separation of mexiletine, and two of the main metabolites of mexiletine, p-hydroxymexiletine (PHM, 2 Fig. 1) , and hydroxymethylmexiletine (HMM, 4) [17] . In the last decade we performed efficient syntheses for the preparation of mexiletine and its major metabolites, PHM, HMM and Nhydroxymexiletine (NHM, 3) which were extensively evaluated on voltage-gated sodium channels [18] [19] [20] [21] [22] . Moreover, we prepared the N-carbonyloxy -D-glucuronide of mexiletine [23] . In the present paper, we report a capillary zone electrophoretic (CZE) method for the separation and quantitative determination of mexiletine (1) and its main phase I metabolites (2) (3) (4) . Moreover, the oxazepine derivative 5, the main nitrogenous degradation product of mexiletine, deriving from an oxidative cyclization reaction [24] , was synthesized for the first time and, by using this CZE method, it was also separated and quantitatively determined. pAminomexiletine (6) was also synthesized and used as an internal standard.
MATERIALS AND METHODS

Drugs Synthesis
To a stirring solution of 9 (1.30 g, 4.2 mmol) in 9 mL of trifluoroacetic acid (TFA), NaNO 3 (0.43 g, 5.0 mmol) was added in small portions, at room temperature. After 12 h, excess TFA was removed under vacuum and the residue was taken up with Et 2 O, washed with NaHCO 3 saturated aqueous solution, dried over anhydrous Na 2 To a stirred solution of 11 (0.5 g, 1.5 mmol) in absolute EtOH (20 mL), glacial AcOH (4.5 mmol) and aqueous hydrazine (4.5 mmol) were added and the mixture was kept under reflux for 5 h. The solid residue was filtered off. After evaporation of the filtrate, the residue was taken up with EtOAc and extracted with 2 N HCl (3 x 5 mL); then the aqueous phase was made alkaline with 2 N NaOH and extracted twice with EtOAc. The combined organic layers were dried (Na 2 SO 4 ) and concentrated under vacuum. The final product (6) The combined organic layers were washed with 5% NaHCO 3 , dried (Na 2 SO 4 ), and concentrated under vacuum. The final product (5) was a slightly yellowish oil (30 mg, 27%) whose spectroscopic data were in agreement with the literature [24] .
Analytical Instruments
Infrared spectra were recorded on a Perkin-Elmer (Norwalk, CT) Spectrum One FT spectrophotometer and band positions are given in reciprocal centimeters (cm -1 ). 1 H NMR spectra were recorded on a Varian VX Mercury spectrometer operating at 300 MHz using CDCl 3 and DMSO-d 6 as solvents. Chemical shifts are reported in parts per million (ppm) relative to the residual non-deuterated solvent resonance: CDCl 3 , 7.26 and DMSO-d 6 , 2.48. J values are given in Hz. GC-MS spectra were recorded on a Hewlett-Packard 6890-5973 MSD gas chromatograph/mass spectrometer at low resolution. Elemental analyses were performed on a Eurovector Euro EA 3000 analyzer. Capillary electrophoretic work was performed with a BioFocus Capillary Electrophoresis System 3000 (Bio-Rad Laboratories, Hercules, CA, USA), equipped with a UV-visible detector (190-700 nm range). The electrophoretic runs were made at 18 °C. The samples were loaded by hydrodynamic injection (10 psi). The uncoated fused silica capillary (0.050 mm ID) was from Quadrex Corporation (Woodbridge, CT, USA). The length of the capillary was 70 cm (65 cm to detector) and the wavelength detection was 214 nm. The capillary was conditioned initially and between every injection by flushing with 0.1 N NaOH for 3 min followed by 3 min water and 6 min buffer. Chromatographic separations were performed on silica gel columns by flash chromatography (Kieselgel 60, 0.040-0.063 mm, Merck, Darmstadt, Germany) as previously described [25] [26] [27] . TLC analyses were performed on precoated silica gel on aluminum sheets (Kieselgel 60 F 254 , Merck). Melting points were determined on a Gallenkamp apparatus in open glass capillary tubes and are uncorrected.
Chemicals
Compounds 1-4 and 8,9 were prepared in our laboratories as previously described [18] [19] [20] [21] 28, 29] . Stock   Fig. (1) . Structures of mexiletine (1), para-hydroxymexiletine (2) , N-hydroxymexiletine (3), hydroxymethylmexiletine (4), 3,9-dimethyl-2,3-dihydro-1,4-benzoxazepine (5), and p-aminomexiletine (6 solutions containing 10 mg mL -1 of each compound were prepared in distilled water. The solutions were suitably diluted for the analysis. Buffer solutions were prepared with phosphoric acid, sodium dihydrogen phosphate, and disodium hydrogen phosphate (Sigma-Aldrich). Distilleddeionized water (Millipore, Billerica, MA, USA) was used throughout. Sodium hydroxide (99% purity; Merck, Darmstadt, Germany) was used to prepare the capillary conditioning solutions. Samples solutions were prepared opportunely diluting with water the stock solutions.
RESULTS AND DISCUSSION
The simultaneous separation and quantification of the analytes within the minimum analysis time and the maximum resolution and efficiency are the main objectives in the development of a CE method for the determination of solutes. The method presented herein describes a specific, sensitive, and reproducible technique using CZE with internal standard and UV detection for the separation and quantification of mexiletine (1), its main metabolites (2 4), and its main nitrogenous degradation product (5). This method guarantees high-resolution separations at a minimal cost in terms of sample size, reagent consumption, and operator time. Compounds 5 and 6 were prepared in this work, too.
Separation of Compounds 1-5
Using the analytes concentrations (1-6) and conditions reported in Fig. (2) , we obtained 6 baseline resolved peaks. Migration times were all under 17 minutes. A fractional factorial design of experiments (DoE) was used to evaluate the robustness of the method. The operating conditions (factors) which could have an influence on the assay performance were identified and their effects on the assay results were studied. Thus, analytes concentrations (20% up and down the concentration shown in the figure), buffer pH (3.2 ± 0.2), temperature (18 ± 3 °C), injection pressure (10 ± 2 psi) and voltage (20 ± 2 kV) were examined. The robustness testing through DoE showed that this analytical procedure is robust in the investigated experimental space.
Quantitative Determination of Compounds 1 5
A calibration curve was determined for each compound using the general equation y = ax + b (Fig. 3) . The ratio between the areas of each analyte peak and the internal standard peak (S A /S IS ) was plotted as a function of the ratio between analyte and internal standard concentrations (M A /M IS ). The calibration curves were obtained using five different concentrations. R 2 values found were all higher than 0.98. As an example, the calibration curve of mexiletine is shown in Fig. (4) .
Synthesis of Compounds 5 and 6
The preparation of compound 5 was performed by oxidation of HMM (4) (Scheme 1). The synthetic route adopted for the synthesis of p-aminomexiletine (6) is shown in Scheme 2. It starts from the efficient protection of the commercially available 2-aminopropanol (7) with phthalic anhydride [30, 31] . The phthalimido alcohol 8 is submitted to condensation with 2,6-dimethylphenol, under Mitsunobu conditions as previously reported [32, 33] . Nitration of compound 9 gave the nitroderivative 10. The successive reduction reaction [34] brought to aniline 11 which was deprotected by hydrazinolysis [35] to give the desired amine 6. 
CONCLUSION
A specific, sensitive and robust method using CZE with internal standard and UV detection is applied for the first time to the separation and quantification of mexiletine, its major metabolites (PHM, HMM, NHM), and its main nitrogenous degradation product (5) . Moreover, the semimicro preparation (tens of milligrams) of compound 5 and paminomexiletine (6) was performed. The electrophoretic method herein described may be useful in principle for the quantification of another mexiletine metabolite recently prepared, m-hydroxymexiletine (MHM), which showed interesting pharmacodynamic properties [36] [37] [38] [39] . More recently, CE using -cyclodextrin sulfated sodium salt was successfully employed for the chiral separation of MHM enantiomers, too [40] .
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